| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 14 | 2026 | 691 | 3.060 |
Why?
|
| Macrophages | 57 | 2018 | 1511 | 2.920 |
Why?
|
| Pulmonary Fibrosis | 19 | 2026 | 395 | 2.640 |
Why?
|
| Lung | 32 | 2026 | 4109 | 2.220 |
Why?
|
| Fibroblasts | 18 | 2026 | 1034 | 2.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 34 | 2014 | 1217 | 2.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 13 | 2005 | 163 | 1.880 |
Why?
|
| Apoptosis | 22 | 2026 | 2430 | 1.760 |
Why?
|
| Bleomycin | 16 | 2026 | 253 | 1.670 |
Why?
|
| fas Receptor | 7 | 2020 | 92 | 1.350 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 14 | 2010 | 81 | 1.290 |
Why?
|
| Antigens, CD | 12 | 2004 | 555 | 1.280 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2026 | 241 | 1.270 |
Why?
|
| Signal Transduction | 28 | 2026 | 5233 | 1.210 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 11 | 2005 | 175 | 1.170 |
Why?
|
| Arthritis, Experimental | 3 | 2018 | 141 | 1.150 |
Why?
|
| Mice | 87 | 2026 | 18365 | 1.090 |
Why?
|
| Macrophages, Alveolar | 10 | 2014 | 368 | 1.070 |
Why?
|
| Insulin-Like Growth Factor I | 10 | 2009 | 319 | 1.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 9 | 1999 | 168 | 0.960 |
Why?
|
| Mitogen-Activated Protein Kinases | 12 | 2004 | 292 | 0.950 |
Why?
|
| Animals | 100 | 2026 | 38109 | 0.910 |
Why?
|
| Nitric Oxide Synthase | 6 | 2001 | 235 | 0.870 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 10 | 2002 | 128 | 0.850 |
Why?
|
| Alveolar Epithelial Cells | 6 | 2025 | 120 | 0.810 |
Why?
|
| Mice, Inbred C3H | 30 | 2005 | 251 | 0.790 |
Why?
|
| Trans-Activators | 4 | 2015 | 405 | 0.780 |
Why?
|
| Myofibroblasts | 3 | 2026 | 143 | 0.780 |
Why?
|
| Lung Injury | 3 | 2019 | 237 | 0.740 |
Why?
|
| Interferon-gamma | 14 | 2010 | 784 | 0.720 |
Why?
|
| Collagen | 6 | 2018 | 456 | 0.710 |
Why?
|
| Indoles | 3 | 2026 | 501 | 0.700 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 11 | 2011 | 153 | 0.680 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 2 | 2018 | 8 | 0.680 |
Why?
|
| Pulmonary Emphysema | 1 | 2024 | 275 | 0.670 |
Why?
|
| Epithelial Cells | 9 | 2023 | 1126 | 0.660 |
Why?
|
| TRPC Cation Channels | 2 | 2010 | 14 | 0.650 |
Why?
|
| Immunity, Innate | 4 | 2018 | 846 | 0.640 |
Why?
|
| Cells, Cultured | 29 | 2020 | 4155 | 0.600 |
Why?
|
| Macrophage Activation | 11 | 2009 | 193 | 0.550 |
Why?
|
| NF-kappa B | 7 | 2009 | 662 | 0.550 |
Why?
|
| Pneumonia | 6 | 2018 | 631 | 0.540 |
Why?
|
| MAP Kinase Kinase 4 | 5 | 2002 | 23 | 0.510 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2024 | 923 | 0.490 |
Why?
|
| Interleukin-4 | 4 | 2008 | 206 | 0.490 |
Why?
|
| Disease Models, Animal | 9 | 2026 | 4569 | 0.490 |
Why?
|
| Lung Diseases, Interstitial | 4 | 2023 | 660 | 0.480 |
Why?
|
| Cell Line | 16 | 2019 | 2882 | 0.470 |
Why?
|
| Lipopolysaccharides | 9 | 2012 | 863 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 21 | 2026 | 5997 | 0.460 |
Why?
|
| Transforming Growth Factor beta | 9 | 2020 | 479 | 0.460 |
Why?
|
| Mice, Knockout | 14 | 2020 | 3125 | 0.450 |
Why?
|
| Serum Response Factor | 1 | 2015 | 33 | 0.440 |
Why?
|
| TNF Receptor-Associated Factor 2 | 4 | 2010 | 8 | 0.440 |
Why?
|
| Monocytes | 7 | 2018 | 538 | 0.430 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 1999 | 433 | 0.430 |
Why?
|
| Mesoderm | 1 | 2015 | 150 | 0.410 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 2 | 2026 | 280 | 0.410 |
Why?
|
| Interleukin-8 | 6 | 2009 | 271 | 0.400 |
Why?
|
| Sodium Chloride | 2 | 2006 | 142 | 0.400 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2013 | 1169 | 0.390 |
Why?
|
| Acute Lung Injury | 2 | 2017 | 303 | 0.380 |
Why?
|
| Phosphorylation | 16 | 2020 | 1733 | 0.370 |
Why?
|
| Bone Marrow Cells | 10 | 2012 | 320 | 0.360 |
Why?
|
| Dendritic Cells | 3 | 2013 | 499 | 0.360 |
Why?
|
| Neutrophils | 9 | 2018 | 1134 | 0.350 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2009 | 19 | 0.340 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2010 | 4 | 0.330 |
Why?
|
| Lung Diseases | 4 | 2013 | 787 | 0.330 |
Why?
|
| beta-Glucans | 5 | 1993 | 16 | 0.330 |
Why?
|
| Humans | 65 | 2026 | 144957 | 0.320 |
Why?
|
| Up-Regulation | 4 | 2012 | 852 | 0.320 |
Why?
|
| Phagocytosis | 8 | 2012 | 299 | 0.320 |
Why?
|
| Nitric Oxide | 5 | 2010 | 897 | 0.320 |
Why?
|
| Adaptive Immunity | 1 | 2011 | 169 | 0.310 |
Why?
|
| Enzyme Activation | 13 | 2011 | 768 | 0.310 |
Why?
|
| Actins | 6 | 2026 | 425 | 0.300 |
Why?
|
| X-Ray Microtomography | 2 | 2021 | 107 | 0.300 |
Why?
|
| Molecular Sequence Data | 12 | 2010 | 2931 | 0.300 |
Why?
|
| RNA, Messenger | 18 | 2011 | 2832 | 0.300 |
Why?
|
| Silicosis | 2 | 2023 | 30 | 0.300 |
Why?
|
| Calcium | 3 | 2010 | 1184 | 0.300 |
Why?
|
| Transcription, Genetic | 6 | 2014 | 1496 | 0.290 |
Why?
|
| Testosterone | 1 | 2013 | 419 | 0.290 |
Why?
|
| Bronchoalveolar Lavage Fluid | 7 | 2011 | 636 | 0.290 |
Why?
|
| Lung Compliance | 3 | 2014 | 42 | 0.280 |
Why?
|
| Inflammation Mediators | 4 | 2018 | 509 | 0.280 |
Why?
|
| Cytokines | 8 | 2018 | 2065 | 0.270 |
Why?
|
| Gene Expression Regulation | 8 | 2010 | 2609 | 0.270 |
Why?
|
| Poly I-C | 6 | 1994 | 57 | 0.260 |
Why?
|
| Interleukin-13 | 2 | 2010 | 144 | 0.260 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 2 | 2020 | 22 | 0.260 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 2 | 1999 | 19 | 0.260 |
Why?
|
| Chemokines | 2 | 2006 | 218 | 0.260 |
Why?
|
| Autoimmunity | 1 | 2013 | 927 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 5 | 2008 | 1258 | 0.250 |
Why?
|
| Respiratory Mucosa | 5 | 2025 | 322 | 0.250 |
Why?
|
| Inflammation | 8 | 2024 | 2880 | 0.250 |
Why?
|
| Male | 30 | 2026 | 72406 | 0.250 |
Why?
|
| Transcription Factor AP-1 | 2 | 2006 | 79 | 0.250 |
Why?
|
| Lysosomes | 6 | 1993 | 128 | 0.240 |
Why?
|
| Pulmonary Alveoli | 4 | 2025 | 383 | 0.240 |
Why?
|
| Nitric Oxide Synthase Type II | 7 | 2008 | 162 | 0.240 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2024 | 187 | 0.240 |
Why?
|
| Th2 Cells | 2 | 2004 | 171 | 0.240 |
Why?
|
| Gene Expression | 5 | 2012 | 1490 | 0.240 |
Why?
|
| Membrane Microdomains | 2 | 2004 | 34 | 0.230 |
Why?
|
| Granulomatous Disease, Chronic | 3 | 2010 | 48 | 0.230 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2026 | 54 | 0.230 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 9 | 2012 | 266 | 0.230 |
Why?
|
| Enzyme Induction | 8 | 2008 | 88 | 0.230 |
Why?
|
| MAP Kinase Kinase 1 | 6 | 2001 | 71 | 0.220 |
Why?
|
| Sulfonamides | 2 | 2026 | 581 | 0.220 |
Why?
|
| 5' Untranslated Regions | 1 | 2005 | 59 | 0.220 |
Why?
|
| Proline | 1 | 2005 | 83 | 0.210 |
Why?
|
| Recombinant Proteins | 6 | 2010 | 1371 | 0.210 |
Why?
|
| Flow Cytometry | 3 | 2020 | 1173 | 0.210 |
Why?
|
| Dual Specificity Phosphatase 1 | 3 | 2012 | 23 | 0.210 |
Why?
|
| Keratin-8 | 1 | 2023 | 4 | 0.210 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2003 | 5 | 0.210 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2013 | 428 | 0.200 |
Why?
|
| Cellular Senescence | 1 | 2026 | 226 | 0.200 |
Why?
|
| Models, Biological | 3 | 2025 | 1822 | 0.190 |
Why?
|
| Proteins | 5 | 2004 | 1022 | 0.190 |
Why?
|
| Precancerous Conditions | 1 | 2004 | 166 | 0.190 |
Why?
|
| Transfection | 5 | 2009 | 940 | 0.190 |
Why?
|
| Growth Substances | 4 | 2004 | 140 | 0.190 |
Why?
|
| I-kappa B Proteins | 2 | 2012 | 74 | 0.190 |
Why?
|
| Respiratory System | 1 | 2024 | 149 | 0.190 |
Why?
|
| Stem Cells | 2 | 2019 | 627 | 0.190 |
Why?
|
| Endoplasmic Reticulum | 4 | 2011 | 266 | 0.190 |
Why?
|
| Adenoma | 1 | 2004 | 218 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2025 | 276 | 0.180 |
Why?
|
| Complement Factor B | 5 | 1994 | 106 | 0.180 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2010 | 381 | 0.180 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 210 | 0.180 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 1786 | 0.180 |
Why?
|
| Female | 25 | 2024 | 78376 | 0.180 |
Why?
|
| Mitochondrial Proteins | 1 | 2024 | 263 | 0.170 |
Why?
|
| Cystic Fibrosis | 4 | 2008 | 1158 | 0.170 |
Why?
|
| COS Cells | 5 | 2005 | 181 | 0.170 |
Why?
|
| Base Sequence | 8 | 2009 | 2191 | 0.170 |
Why?
|
| Biocompatible Materials | 1 | 2025 | 435 | 0.170 |
Why?
|
| Amino Acid Sequence | 5 | 2010 | 2157 | 0.170 |
Why?
|
| Lymph Nodes | 3 | 2013 | 502 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 6 | 2012 | 1253 | 0.170 |
Why?
|
| Receptors, Cell Surface | 5 | 2009 | 377 | 0.160 |
Why?
|
| Mice, Mutant Strains | 3 | 2011 | 299 | 0.160 |
Why?
|
| Cell Communication | 2 | 2018 | 324 | 0.160 |
Why?
|
| Glucans | 6 | 1995 | 22 | 0.160 |
Why?
|
| Cell Differentiation | 5 | 2023 | 2050 | 0.160 |
Why?
|
| Transcription Factors | 3 | 2011 | 1742 | 0.160 |
Why?
|
| Interferon-beta | 4 | 1994 | 92 | 0.160 |
Why?
|
| Reference Values | 2 | 2018 | 798 | 0.150 |
Why?
|
| Smoke | 2 | 2011 | 148 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 3 | 2012 | 311 | 0.150 |
Why?
|
| Disease Progression | 3 | 2025 | 2852 | 0.150 |
Why?
|
| TNF Receptor-Associated Factor 1 | 4 | 2003 | 8 | 0.150 |
Why?
|
| Annexin A4 | 1 | 1999 | 6 | 0.150 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2019 | 23 | 0.150 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 28 | 0.150 |
Why?
|
| Cell Survival | 5 | 2013 | 1098 | 0.150 |
Why?
|
| Hydrogels | 2 | 2025 | 700 | 0.150 |
Why?
|
| Phosphatidylserines | 4 | 2008 | 60 | 0.150 |
Why?
|
| Mice, Transgenic | 4 | 2019 | 2185 | 0.150 |
Why?
|
| HeLa Cells | 5 | 2013 | 650 | 0.140 |
Why?
|
| Fibrosis | 3 | 2019 | 548 | 0.140 |
Why?
|
| Drug Resistance, Microbial | 1 | 2018 | 70 | 0.140 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 83 | 0.140 |
Why?
|
| Cell Membrane | 4 | 2010 | 706 | 0.140 |
Why?
|
| Down-Regulation | 2 | 2018 | 627 | 0.140 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 183 | 0.140 |
Why?
|
| Case-Control Studies | 3 | 2018 | 3608 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2001 | 460 | 0.130 |
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 1997 | 19 | 0.130 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 1718 | 0.130 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2001 | 337 | 0.130 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 359 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 583 | 0.130 |
Why?
|
| Extracellular Matrix | 3 | 2019 | 553 | 0.130 |
Why?
|
| Kinetics | 6 | 2004 | 1629 | 0.120 |
Why?
|
| Homeostasis | 1 | 2020 | 640 | 0.120 |
Why?
|
| Sex Characteristics | 2 | 2013 | 791 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 3 | 2005 | 862 | 0.120 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 635 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2012 | 851 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 749 | 0.120 |
Why?
|
| Protein Transport | 4 | 2011 | 441 | 0.120 |
Why?
|
| Lung Neoplasms | 2 | 2009 | 2642 | 0.110 |
Why?
|
| NADPH Oxidases | 3 | 2010 | 124 | 0.110 |
Why?
|
| Interleukin-10 | 1 | 1997 | 310 | 0.110 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2006 | 87 | 0.110 |
Why?
|
| Enzyme Inhibitors | 4 | 2010 | 826 | 0.110 |
Why?
|
| Platelet Activating Factor | 2 | 1995 | 49 | 0.110 |
Why?
|
| DNA-Binding Proteins | 4 | 2005 | 1500 | 0.110 |
Why?
|
| Fas Ligand Protein | 2 | 2013 | 60 | 0.110 |
Why?
|
| Blotting, Western | 6 | 2015 | 1187 | 0.110 |
Why?
|
| Permeability | 2 | 2017 | 168 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 298 | 0.110 |
Why?
|
| Asbestos | 2 | 1993 | 36 | 0.110 |
Why?
|
| Hyaluronic Acid | 2 | 1994 | 208 | 0.110 |
Why?
|
| Biomarkers | 2 | 2024 | 4275 | 0.110 |
Why?
|
| Hydroxyproline | 1 | 2014 | 18 | 0.110 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 11 | 0.110 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2014 | 26 | 0.100 |
Why?
|
| Binding Sites | 2 | 2010 | 1331 | 0.100 |
Why?
|
| Receptors, Immunologic | 2 | 2015 | 206 | 0.100 |
Why?
|
| Sequence Deletion | 2 | 2005 | 193 | 0.100 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2009 | 370 | 0.100 |
Why?
|
| Fas-Associated Death Domain Protein | 2 | 2005 | 9 | 0.100 |
Why?
|
| Interferons | 2 | 1998 | 188 | 0.100 |
Why?
|
| Consensus Sequence | 2 | 2005 | 74 | 0.100 |
Why?
|
| Bronchiolitis Obliterans | 1 | 1994 | 66 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2009 | 437 | 0.100 |
Why?
|
| Endocytosis | 2 | 2011 | 168 | 0.100 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1993 | 15 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2004 | 623 | 0.100 |
Why?
|
| Risk Factors | 3 | 2024 | 10792 | 0.100 |
Why?
|
| Remission Induction | 1 | 2014 | 308 | 0.100 |
Why?
|
| Fibronectins | 1 | 1994 | 136 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 5 | 2012 | 1054 | 0.100 |
Why?
|
| Proteolysis | 1 | 2013 | 173 | 0.100 |
Why?
|
| Extracellular Vesicles | 1 | 2015 | 171 | 0.100 |
Why?
|
| Cytoplasm | 2 | 2005 | 269 | 0.090 |
Why?
|
| Chemokine CXCL1 | 2 | 2011 | 76 | 0.090 |
Why?
|
| Drug Synergism | 3 | 2003 | 357 | 0.090 |
Why?
|
| Protein Kinase C | 1 | 1994 | 252 | 0.090 |
Why?
|
| Anthrax | 1 | 2012 | 9 | 0.090 |
Why?
|
| Bacillus anthracis | 1 | 2012 | 13 | 0.090 |
Why?
|
| Transcriptional Activation | 2 | 2005 | 383 | 0.090 |
Why?
|
| Delayed-Action Preparations | 1 | 2012 | 183 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2013 | 376 | 0.090 |
Why?
|
| GTPase-Activating Proteins | 1 | 2012 | 82 | 0.090 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2011 | 27 | 0.090 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2012 | 61 | 0.090 |
Why?
|
| Autophagy | 1 | 2013 | 286 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 140 | 0.080 |
Why?
|
| Okadaic Acid | 2 | 2001 | 15 | 0.080 |
Why?
|
| Leukotrienes | 1 | 1991 | 27 | 0.080 |
Why?
|
| Microscopy, Electron | 3 | 2015 | 415 | 0.080 |
Why?
|
| Trauma Severity Indices | 1 | 2011 | 112 | 0.080 |
Why?
|
| Receptors, Lipoprotein | 1 | 1991 | 16 | 0.080 |
Why?
|
| Pyridones | 1 | 2012 | 199 | 0.080 |
Why?
|
| Peritonitis | 2 | 2010 | 84 | 0.080 |
Why?
|
| Receptors, IgG | 3 | 2009 | 76 | 0.080 |
Why?
|
| Oxidative Stress | 3 | 2015 | 1339 | 0.080 |
Why?
|
| Wound Healing | 2 | 2017 | 351 | 0.080 |
Why?
|
| Chemokine CXCL2 | 2 | 2010 | 41 | 0.080 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2011 | 72 | 0.080 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 541 | 0.080 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2011 | 120 | 0.080 |
Why?
|
| Lipoproteins, LDL | 1 | 1991 | 119 | 0.080 |
Why?
|
| Schistosoma mansoni | 1 | 2010 | 41 | 0.080 |
Why?
|
| Antigen Presentation | 1 | 2011 | 205 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2004 | 138 | 0.080 |
Why?
|
| Schistosomiasis | 1 | 2010 | 49 | 0.080 |
Why?
|
| Granuloma | 1 | 2010 | 96 | 0.080 |
Why?
|
| Protein Binding | 5 | 2013 | 2276 | 0.080 |
Why?
|
| Nitrites | 2 | 2001 | 89 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 157 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2017 | 2499 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2014 | 710 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 338 | 0.080 |
Why?
|
| Thiazolidinediones | 1 | 2010 | 139 | 0.080 |
Why?
|
| NIH 3T3 Cells | 2 | 2014 | 148 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2010 | 177 | 0.070 |
Why?
|
| Antigens | 1 | 2011 | 347 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2015 | 701 | 0.070 |
Why?
|
| Elastin | 1 | 2009 | 79 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2009 | 124 | 0.070 |
Why?
|
| Asthma | 2 | 2012 | 1768 | 0.070 |
Why?
|
| Mitochondria | 1 | 2015 | 984 | 0.070 |
Why?
|
| Mutation | 4 | 2008 | 4099 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 173 | 0.070 |
Why?
|
| Myoblasts | 1 | 2009 | 84 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 301 | 0.070 |
Why?
|
| Interleukin-1 | 3 | 2001 | 961 | 0.070 |
Why?
|
| Vitamin D | 1 | 2012 | 400 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 2011 | 252 | 0.070 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2001 | 153 | 0.070 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2009 | 90 | 0.070 |
Why?
|
| Glucocorticoids | 2 | 2012 | 535 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 381 | 0.070 |
Why?
|
| Intubation, Intratracheal | 1 | 2011 | 320 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2005 | 477 | 0.070 |
Why?
|
| Gene Amplification | 1 | 2008 | 121 | 0.070 |
Why?
|
| Time Factors | 3 | 2014 | 7183 | 0.070 |
Why?
|
| Prednisone | 1 | 2008 | 221 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2009 | 395 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2008 | 78 | 0.060 |
Why?
|
| Interferon Type I | 1 | 1988 | 145 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 1998 | 41 | 0.060 |
Why?
|
| Genes, Reporter | 2 | 2014 | 276 | 0.060 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 708 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2019 | 475 | 0.060 |
Why?
|
| Chromatography, Ion Exchange | 2 | 1997 | 57 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 877 | 0.060 |
Why?
|
| Nanoparticles | 1 | 2012 | 520 | 0.060 |
Why?
|
| Survival Rate | 1 | 2011 | 2092 | 0.060 |
Why?
|
| Genetic Vectors | 2 | 2011 | 337 | 0.060 |
Why?
|
| Vaccines | 1 | 2011 | 389 | 0.060 |
Why?
|
| Middle Aged | 8 | 2012 | 35928 | 0.060 |
Why?
|
| Glucuronidase | 3 | 1993 | 25 | 0.060 |
Why?
|
| Adenine Nucleotides | 1 | 1985 | 21 | 0.060 |
Why?
|
| Collagen Type I | 1 | 2026 | 147 | 0.060 |
Why?
|
| Bronchoalveolar Lavage | 2 | 2012 | 89 | 0.060 |
Why?
|
| Metalloendopeptidases | 1 | 2005 | 62 | 0.060 |
Why?
|
| Asparagine | 1 | 2005 | 35 | 0.060 |
Why?
|
| Sp3 Transcription Factor | 1 | 2005 | 6 | 0.060 |
Why?
|
| Sex Factors | 1 | 2011 | 2114 | 0.060 |
Why?
|
| Bone Marrow | 3 | 2004 | 306 | 0.050 |
Why?
|
| Golgi Apparatus | 2 | 2005 | 100 | 0.050 |
Why?
|
| Antibodies | 2 | 1998 | 403 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2025 | 246 | 0.050 |
Why?
|
| Luciferases | 1 | 2005 | 152 | 0.050 |
Why?
|
| Colorado | 1 | 2015 | 4564 | 0.050 |
Why?
|
| Dinoprostone | 3 | 1995 | 178 | 0.050 |
Why?
|
| Serine | 1 | 2005 | 145 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2004 | 174 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2004 | 111 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 1991 | 1167 | 0.050 |
Why?
|
| Point Mutation | 1 | 2005 | 243 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 304 | 0.050 |
Why?
|
| Phenotype | 4 | 2019 | 3164 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 983 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2013 | 675 | 0.050 |
Why?
|
| CD36 Antigens | 1 | 2004 | 32 | 0.050 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2004 | 34 | 0.050 |
Why?
|
| TNF Receptor-Associated Death Domain Protein | 1 | 2003 | 2 | 0.050 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2003 | 14 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 4 | 1999 | 1524 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 139 | 0.050 |
Why?
|
| STAT6 Transcription Factor | 1 | 2003 | 24 | 0.050 |
Why?
|
| Age Factors | 1 | 2011 | 3335 | 0.050 |
Why?
|
| Exons | 1 | 2005 | 358 | 0.050 |
Why?
|
| STAT1 Transcription Factor | 1 | 2003 | 68 | 0.050 |
Why?
|
| In Vitro Techniques | 3 | 1991 | 1048 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 2947 | 0.050 |
Why?
|
| Blood Proteins | 2 | 2001 | 249 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 1993 | 90 | 0.050 |
Why?
|
| Calcimycin | 2 | 1994 | 36 | 0.050 |
Why?
|
| Chromones | 1 | 2002 | 42 | 0.050 |
Why?
|
| Osmotic Pressure | 1 | 2002 | 39 | 0.050 |
Why?
|
| Silicon Dioxide | 1 | 2003 | 121 | 0.050 |
Why?
|
| Thorax | 1 | 2022 | 50 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2004 | 418 | 0.050 |
Why?
|
| Aniline Compounds | 1 | 2023 | 119 | 0.050 |
Why?
|
| Phosphoamino Acids | 1 | 2001 | 1 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2001 | 5 | 0.040 |
Why?
|
| Adenoviridae | 2 | 2014 | 199 | 0.040 |
Why?
|
| Beclomethasone | 1 | 2001 | 8 | 0.040 |
Why?
|
| Flavonoids | 1 | 2002 | 87 | 0.040 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2001 | 31 | 0.040 |
Why?
|
| Morpholines | 1 | 2002 | 129 | 0.040 |
Why?
|
| Jurkat Cells | 2 | 2013 | 114 | 0.040 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2001 | 8 | 0.040 |
Why?
|
| Adrenal Glands | 1 | 2001 | 77 | 0.040 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2001 | 49 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 2147 | 0.040 |
Why?
|
| Genes, bcl-2 | 1 | 2001 | 22 | 0.040 |
Why?
|
| Caspase 8 | 1 | 2001 | 47 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2001 | 101 | 0.040 |
Why?
|
| Caspase 9 | 1 | 2001 | 55 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 121 | 0.040 |
Why?
|
| Rats | 3 | 2017 | 5614 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2014 | 389 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2001 | 139 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2011 | 7997 | 0.040 |
Why?
|
| Aged | 4 | 2009 | 25947 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2025 | 655 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 2365 | 0.040 |
Why?
|
| Phosphopeptides | 1 | 2000 | 20 | 0.040 |
Why?
|
| Hydrolases | 2 | 1993 | 55 | 0.040 |
Why?
|
| Peptide Mapping | 1 | 2000 | 63 | 0.040 |
Why?
|
| Caspases | 1 | 2001 | 232 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2000 | 65 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2001 | 300 | 0.040 |
Why?
|
| NADPH Oxidase 2 | 2 | 2010 | 35 | 0.040 |
Why?
|
| Protein Phosphatase 2 | 1 | 2000 | 41 | 0.040 |
Why?
|
| Imidazoles | 1 | 2001 | 254 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2000 | 327 | 0.040 |
Why?
|
| Transcriptome | 1 | 2026 | 1046 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2000 | 145 | 0.040 |
Why?
|
| Sepharose | 1 | 1999 | 32 | 0.040 |
Why?
|
| Nitrobenzoates | 1 | 1998 | 1 | 0.040 |
Why?
|
| Obesity | 1 | 2012 | 3082 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2000 | 392 | 0.040 |
Why?
|
| Adult | 8 | 2012 | 40506 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2001 | 573 | 0.040 |
Why?
|
| Indomethacin | 2 | 1991 | 76 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 1999 | 156 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1999 | 277 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2010 | 1980 | 0.040 |
Why?
|
| Scleroderma, Systemic | 1 | 2019 | 123 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 396 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1998 | 65 | 0.030 |
Why?
|
| Dexamethasone | 2 | 2012 | 372 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 758 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 1998 | 43 | 0.030 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 1997 | 6 | 0.030 |
Why?
|
| Chemokines, CXC | 1 | 1998 | 68 | 0.030 |
Why?
|
| DNA Probes | 1 | 1997 | 59 | 0.030 |
Why?
|
| Phospholipids | 1 | 1999 | 213 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1998 | 401 | 0.030 |
Why?
|
| Adaptation, Physiological | 2 | 1995 | 570 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2008 | 780 | 0.030 |
Why?
|
| Regeneration | 1 | 2019 | 197 | 0.030 |
Why?
|
| Cilia | 1 | 1998 | 173 | 0.030 |
Why?
|
| Reactive Oxygen Species | 2 | 2010 | 621 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2017 | 89 | 0.030 |
Why?
|
| Cell Division | 1 | 1998 | 766 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2017 | 91 | 0.030 |
Why?
|
| Membrane Glycoproteins | 2 | 2010 | 496 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2001 | 464 | 0.030 |
Why?
|
| Catalysis | 1 | 1997 | 322 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2001 | 737 | 0.030 |
Why?
|
| Pyridines | 1 | 2001 | 605 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 1998 | 204 | 0.030 |
Why?
|
| Complement C3 | 2 | 1988 | 191 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1998 | 381 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 2540 | 0.030 |
Why?
|
| Arrestins | 1 | 2015 | 14 | 0.030 |
Why?
|
| Receptor Aggregation | 1 | 1995 | 10 | 0.030 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2015 | 37 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 824 | 0.030 |
Why?
|
| Cell Movement | 2 | 2013 | 965 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1997 | 382 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 2456 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1995 | 45 | 0.030 |
Why?
|
| Pancreatic Elastase | 1 | 1995 | 55 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1997 | 315 | 0.030 |
Why?
|
| Leukocyte Elastase | 1 | 1995 | 75 | 0.030 |
Why?
|
| Regression Analysis | 1 | 1997 | 1003 | 0.030 |
Why?
|
| Eosinophils | 1 | 1997 | 316 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 116 | 0.030 |
Why?
|
| Cell-Derived Microparticles | 1 | 2015 | 75 | 0.030 |
Why?
|
| Exosomes | 1 | 2015 | 104 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 557 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 1995 | 316 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2015 | 194 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 2925 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2014 | 43 | 0.030 |
Why?
|
| Sequestosome-1 Protein | 1 | 2013 | 15 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 57 | 0.030 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1995 | 102 | 0.030 |
Why?
|
| Forecasting | 1 | 1995 | 391 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2010 | 1311 | 0.030 |
Why?
|
| Chloroquine | 1 | 2013 | 53 | 0.030 |
Why?
|
| beta-N-Acetylhexosaminidases | 2 | 1991 | 9 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2013 | 40 | 0.030 |
Why?
|
| Macrophages, Peritoneal | 1 | 1993 | 89 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1995 | 233 | 0.020 |
Why?
|
| Eicosanoids | 1 | 1993 | 58 | 0.020 |
Why?
|
| Culture Media | 1 | 2013 | 161 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 276 | 0.020 |
Why?
|
| Zymosan | 2 | 2010 | 39 | 0.020 |
Why?
|
| Polyglactin 910 | 1 | 2012 | 6 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 970 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1994 | 299 | 0.020 |
Why?
|
| PPAR delta | 1 | 2012 | 6 | 0.020 |
Why?
|
| Endothelium | 1 | 2013 | 119 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2013 | 165 | 0.020 |
Why?
|
| Receptors, Chemokine | 1 | 2012 | 47 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2012 | 19 | 0.020 |
Why?
|
| Diterpenes | 1 | 2012 | 26 | 0.020 |
Why?
|
| Cell Separation | 1 | 1993 | 307 | 0.020 |
Why?
|
| Ionomycin | 1 | 1992 | 22 | 0.020 |
Why?
|
| Prone Position | 1 | 2012 | 24 | 0.020 |
Why?
|
| Receptors, CCR7 | 1 | 2012 | 31 | 0.020 |
Why?
|
| Supine Position | 1 | 2012 | 37 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 1993 | 322 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 405 | 0.020 |
Why?
|
| Autoradiography | 1 | 1991 | 65 | 0.020 |
Why?
|
| Young Adult | 1 | 2009 | 14126 | 0.020 |
Why?
|
| Sarcoidosis | 1 | 1994 | 160 | 0.020 |
Why?
|
| Anions | 1 | 1991 | 31 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 86 | 0.020 |
Why?
|
| Berylliosis | 1 | 1994 | 202 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 364 | 0.020 |
Why?
|
| Aldehydes | 1 | 2012 | 142 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2012 | 132 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 3890 | 0.020 |
Why?
|
| Caspase 12 | 1 | 2011 | 1 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2011 | 20 | 0.020 |
Why?
|
| Staurosporine | 1 | 2011 | 22 | 0.020 |
Why?
|
| Instillation, Drug | 1 | 2011 | 9 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 56 | 0.020 |
Why?
|
| Receptors, Complement | 1 | 2012 | 125 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2012 | 134 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2011 | 62 | 0.020 |
Why?
|
| Adolescent | 2 | 2009 | 22453 | 0.020 |
Why?
|
| 5,8,11,14-Eicosatetraynoic Acid | 1 | 1991 | 3 | 0.020 |
Why?
|
| SRS-A | 1 | 1991 | 17 | 0.020 |
Why?
|
| Asbestos, Serpentine | 1 | 1991 | 5 | 0.020 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2012 | 138 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1991 | 397 | 0.020 |
Why?
|
| Phospholipases A2 | 1 | 1991 | 79 | 0.020 |
Why?
|
| Scavenger Receptors, Class B | 1 | 1991 | 14 | 0.020 |
Why?
|
| Receptors, Scavenger | 1 | 1991 | 22 | 0.020 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 1991 | 34 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 1992 | 165 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 132 | 0.020 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1991 | 81 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 1990 | 52 | 0.020 |
Why?
|
| Onium Compounds | 1 | 2010 | 8 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 1990 | 74 | 0.020 |
Why?
|
| Phospholipases A | 1 | 1991 | 98 | 0.020 |
Why?
|
| Sputum | 1 | 2012 | 308 | 0.020 |
Why?
|
| Benzoquinones | 1 | 1991 | 47 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 1990 | 54 | 0.020 |
Why?
|
| Phagosomes | 1 | 1990 | 40 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2012 | 284 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1990 | 76 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2010 | 43 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2010 | 37 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 269 | 0.020 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2009 | 9 | 0.020 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2009 | 2 | 0.020 |
Why?
|
| Cadherins | 1 | 2011 | 201 | 0.020 |
Why?
|
| Janus Kinase 2 | 1 | 2009 | 29 | 0.020 |
Why?
|
| Stress Fibers | 1 | 2009 | 18 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2009 | 52 | 0.020 |
Why?
|
| Amiloride | 1 | 2009 | 25 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 2032 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2009 | 52 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2009 | 200 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2011 | 220 | 0.020 |
Why?
|
| beta Catenin | 1 | 2011 | 253 | 0.020 |
Why?
|
| Survivors | 1 | 2013 | 520 | 0.020 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2009 | 19 | 0.020 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2009 | 76 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2009 | 50 | 0.020 |
Why?
|
| Viral Load | 1 | 2011 | 526 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 370 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 44 | 0.020 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2009 | 214 | 0.020 |
Why?
|
| Immune Sera | 1 | 1988 | 77 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 1988 | 76 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2009 | 247 | 0.020 |
Why?
|
| Skin | 1 | 2013 | 758 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 151 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2008 | 153 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2008 | 164 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 481 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2008 | 132 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 494 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 409 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 919 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 1986 | 14 | 0.020 |
Why?
|
| Hexosaminidases | 1 | 1986 | 16 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 911 | 0.020 |
Why?
|
| Methylamines | 1 | 1986 | 40 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1986 | 113 | 0.010 |
Why?
|
| COP-Coated Vesicles | 1 | 2005 | 3 | 0.010 |
Why?
|
| Tubercidin | 1 | 1985 | 1 | 0.010 |
Why?
|
| Secretory Rate | 1 | 1985 | 12 | 0.010 |
Why?
|
| Esterases | 1 | 1985 | 9 | 0.010 |
Why?
|
| ADAM17 Protein | 1 | 2005 | 42 | 0.010 |
Why?
|
| Threonine | 1 | 2005 | 46 | 0.010 |
Why?
|
| Receptors, Purinergic | 1 | 1985 | 20 | 0.010 |
Why?
|
| Theophylline | 1 | 1985 | 41 | 0.010 |
Why?
|
| ADAM Proteins | 1 | 2005 | 63 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2009 | 556 | 0.010 |
Why?
|
| Homocysteine | 1 | 1985 | 151 | 0.010 |
Why?
|
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2004 | 4 | 0.010 |
Why?
|
| Guanine Nucleotides | 1 | 2004 | 12 | 0.010 |
Why?
|
| Cell Surface Extensions | 1 | 2004 | 14 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1985 | 570 | 0.010 |
Why?
|
| Cell Size | 1 | 2004 | 92 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2009 | 984 | 0.010 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2004 | 56 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2004 | 64 | 0.010 |
Why?
|
| Adenosine | 1 | 1985 | 255 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2009 | 757 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1995 | 6434 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1986 | 458 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2004 | 195 | 0.010 |
Why?
|
| Adenine | 1 | 1985 | 339 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 1407 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 1462 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 5965 | 0.010 |
Why?
|
| Airway Resistance | 1 | 2001 | 38 | 0.010 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2001 | 62 | 0.010 |
Why?
|
| Microtubules | 1 | 2004 | 286 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 331 | 0.010 |
Why?
|
| Probability | 1 | 2001 | 312 | 0.010 |
Why?
|
| Infant | 1 | 1995 | 10039 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 427 | 0.010 |
Why?
|
| Quality of Life | 1 | 2013 | 3192 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 2001 | 227 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2001 | 575 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 783 | 0.010 |
Why?
|
| Glucan Endo-1,3-beta-D-Glucosidase | 1 | 1998 | 1 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2001 | 1087 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1995 | 35 | 0.010 |
Why?
|
| Bucladesine | 1 | 1995 | 19 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1995 | 46 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1995 | 27 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2001 | 1890 | 0.010 |
Why?
|
| Child | 2 | 2008 | 22657 | 0.010 |
Why?
|
| Leukotriene C4 | 1 | 1993 | 6 | 0.010 |
Why?
|
| Peritoneal Lavage | 1 | 1993 | 8 | 0.010 |
Why?
|
| Rosette Formation | 1 | 1993 | 14 | 0.010 |
Why?
|
| Diamide | 1 | 1993 | 4 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1993 | 101 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1993 | 187 | 0.010 |
Why?
|
| DNA Primers | 1 | 1994 | 512 | 0.010 |
Why?
|
| Epoprostenol | 1 | 1993 | 131 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 5417 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1993 | 420 | 0.000 |
Why?
|
| Mannans | 1 | 1986 | 5 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2001 | 11695 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1986 | 115 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2001 | 11799 | 0.000 |
Why?
|